Vimarsana
Biggest News Aggregation in the World

Page 20 - Genscript Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genscript Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genscript Biotech Today - Breaking & Trending Today

Researchers evaluate surrogate large-scale SARS-CoV-2 serosurveillance test - Vimarsana News

Researchers evaluate surrogate large-scale SARS-CoV-2 serosurveillance test

A team of international scientists has recently evaluated a surrogate virus neutralization test for severe acute respiratory coronavirus 2 (SARS-CoV-2) and observed that it is highly efficacious for detecting anti-SARS-CoV-2 neutralizing antibodies in serum samples. According to the scientists, the test can be effectively used for population-level serosurveillance and evaluation of vaccine efficacy. The study is currently available on the medRxiv* preprint server.

Recombinant Protein Market Size Is Elastomers to Grow By 6.2% CAGR by 2025 | Global Industry Demand - Vimarsana News

Recombinant Protein Market Size Is Elastomers to Grow By 6.2% CAGR by 2025 | Global Industry Demand

Search jobs 16-Feb-2021 Recombinant Protein Market Size Is Elastomers to Grow By 6.2% CAGR by 2025 | Global Industry Demand by Product, Application, Diagnostic Services and Treatment Recombinant Protein Market – Insights Recombinant proteins are used in development of novel therapies for severe chronic diseases such as cancer and other rare diseases. Recombinant protein production requires a special technique known as recombinant DNA (rDNA) technology. Depending on the type of the protein, recombinant proteins are classified into hormones, growth...

Worldwide CRISPR Gene Editing Industry to 2030 - Players Include Abcam, Applied StemCell and Agilent Technologies Among Others - Vimarsana News

Worldwide CRISPR Gene Editing Industry to 2030 - Players Include Abcam, Applied StemCell and Agilent Technologies Among Others

Share this article Share this article ResearchAndMarkets.com's offering. The global CRISPR gene editing market was valued at $846.2 million in 2019 and is expected to reach $10,825.1 million by 2030, registering a CAGR of 26.86% during the forecast. The development of genome engineering with potential applications proved to reflect a remarkable impact on the future of the healthcare and life science industry. The high efficiency of the CRISPR-Cas9 system has been demonstrated in various studies for genome editing, which resulted in significant investments within the field of genome engineeri...

FactMR: Immunochemicals Market Driven by Increasing Government Investments into Drug Development: Fact.MR - Vimarsana News

FactMR: Immunochemicals Market Driven by Increasing Government Investments into Drug Development: Fact.MR

FactMR: Immunochemicals Market Driven by Increasing Government Investments into Drug Development: Fact.MR Market players are focusing on investing in research for life science studies to fulfill increased demand for antibodies based on research efforts. ROCKVILLE, MD / ACCESSWIRE / December 16, 2020 / The global immunochemicals market is anticipated to register a robust growth rate over the forecast period (2020-2030). Increasing demand for immunochemicals in genetics research and healthcare diagnostics is likely to fuel the growth of the immunochemicals market amid 2020-2030. The COVID-19 pa...